![Xiao Meng Tong](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Xiao Meng Tong
Direktor/Vorstandsmitglied bei
WUXI APPTEC CO., LTD.
Profil
Xiao Meng Tong is currently a Non-Executive Director at WuXi AppTec Co., Ltd. since 2016, an Independent Non-Executive Director at Damai Entertainment Holdings Ltd. since 2014, a Director at CDB Boyu (Shanghai) Investment Management Co., Ltd., and a Partner at Boyu Capital Advisory Co. Ltd. since 2011.
Former positions include Managing Director & Head-Greater China at General Atlantic LP, Director at Wuxi PharmaTech (Cayman), Inc. from 2007 to 2008, Managing Director & Head-Greater China Region at Providence Equity Partners LLC from 2008 to 2011, Managing Director at General Atlantic Asia Ltd. from 2000 to 2008, Non-Executive Director at CStone Pharmaceuticals Co. Ltd. from 2018 to 2019, Director at Guangzhou Kingmed Diagnostics Group Co., Ltd. from 2015 to 2020, Independent Director at Viela Bio, Inc. from 2018 to 2020, Managing Director & Head-Greater China Region at General Atlantic Service Co. LP from 2000 to 2008, Financial Analyst at Morgan Stanley Investment Management, Inc., and Member of The Phi Beta Kappa Society.
Education includes an undergraduate degree from Harvard University conferred in 1998.
Aktive Positionen von Xiao Meng Tong
| Unternehmen | Position | Beginn |
|---|---|---|
| WUXI APPTEC CO., LTD. | Direktor/Vorstandsmitglied | 23.03.2016 |
| DAMAI ENTERTAINMENT HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 27.06.2014 |
Boyu Capital Advisory Co. Ltd.
 Boyu Capital Advisory Co. Ltd. Investment ManagersFinance Boyu Capital invests in companies located across the globe, primarily in China. The firm targets companies operating in the fields of technology, consumer & retail, and healthcare sectors. It provides financing for early stage, buyout and growth stage capital requirements. The firm acquires minority and controlling interest. | Private Equity Investor | 24.03.2011 |
CDB Boyu (Shanghai) Investment Management Co., Ltd.
 CDB Boyu (Shanghai) Investment Management Co., Ltd. Investment ManagersFinance Provides investment management services | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Xiao Meng Tong
| Unternehmen | Position | Ende |
|---|---|---|
| VIELA BIO, INC. | Direktor/Vorstandsmitglied | 18.06.2020 |
| GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. | Direktor/Vorstandsmitglied | 22.01.2020 |
| CSTONE PHARMACEUTICALS | Direktor/Vorstandsmitglied | 15.05.2019 |
Providence Equity Partners LLC
 Providence Equity Partners LLC Investment ManagersFinance Providence Equity Partners invests in middle-market companies located in North America and Europe with enterprise values less than USD 1.5 billion. The firm targets companies operating in the fields of media, technology, communications and education. It provides financing for growth transactions and buyouts. It also has a board seat requirement. | Vorstandsvorsitzender | 01.04.2011 |
| WUXI PHARMATECH (CAYMAN) INC. (ADR) | Direktor/Vorstandsmitglied | 12.10.2008 |
Ausbildung von Xiao Meng Tong
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
83
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
General Atlantic LLC
 General Atlantic LLC Investment ManagersFinance General Atlantic invests in both public and private companies located across the globe. The firm focuses on climate, consumer, financial services, healthcare, life sciences, and technology sectors. It participates in late and growth stage transactions. The firm acquires minority interest. | Finance |
Morgan Stanley Investment Management, Inc.
 Morgan Stanley Investment Management, Inc. Investment ManagersFinance MSIM’s investment strategies span the risk/return spectrum across geographies, investment styles and asset classes, including equity, fixed income, alternatives and private markets. When considering their clients’ unique investment profiles, the firm applies a holistic approach, with a goal of incorporating the different factors affecting investors’ investment decisions. The firm combines top-down country allocation with bottom-up stock selection and disciplined risk management. | Finance |
Wuxi PharmaTech (Cayman), Inc.
 Wuxi PharmaTech (Cayman), Inc. BiotechnologyHealth Technology Engages in contract research, development and manufacturing organization of chemistry drugs and pharmaceuticals | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Providence Equity Partners LLC
Providence Equity Partners LLC Investment ManagersFinance Providence Equity Partners invests in middle-market companies located in North America and Europe with enterprise values less than USD 1.5 billion. The firm targets companies operating in the fields of media, technology, communications and education. It provides financing for growth transactions and buyouts. It also has a board seat requirement. | Finance |
WuXi AppTec Co., Ltd.
 WuXi AppTec Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products & medical devices | Health Technology |
The Phi Beta Kappa Society
 The Phi Beta Kappa Society Miscellaneous Commercial ServicesCommercial Services Operates as a organisation for liberal arts and science education | Commercial Services |
General Atlantic Asia Ltd.
 General Atlantic Asia Ltd. Investment ManagersFinance General Atlantic Asia Ltd invests in companies located in the US. It targets the companies operating in the fields of consumer, financial services, healthcare and Technology. It provides financing for growth transactions. | Finance |
Alibaba Pictures Group Ltd.
 Alibaba Pictures Group Ltd. Movies/EntertainmentConsumer Services Operates as an investment holding company with interest in television and film production, print media and mobile new media | Consumer Services |
Boyu Capital Advisory Co. Ltd.
Boyu Capital Advisory Co. Ltd. Investment ManagersFinance Boyu Capital invests in companies located across the globe, primarily in China. The firm targets companies operating in the fields of technology, consumer & retail, and healthcare sectors. It provides financing for early stage, buyout and growth stage capital requirements. The firm acquires minority and controlling interest. | Finance |
CStone Pharmaceuticals Co. Ltd.
 CStone Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic treatments for oncology, cardiovascular diseases, rheumatoid arthritis, hematology and autoimmune diseases | Health Technology |
Guangzhou Kingmed Diagnostics Group Co., Ltd.
 Guangzhou Kingmed Diagnostics Group Co., Ltd. Medical/Nursing ServicesHealth Services Operates medical laboratory | Health Services |
Viela Bio, Inc.
 Viela Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops treatments for inflammation and autoimmune diseases | Health Technology |
General Atlantic Service Co. LP
 General Atlantic Service Co. LP Financial ConglomeratesFinance Operates as an investment firm | Finance |
CDB Boyu (Shanghai) Investment Management Co., Ltd.
CDB Boyu (Shanghai) Investment Management Co., Ltd. Investment ManagersFinance Provides investment management services | Finance |
